Therapeutic Strategies for Mitigating Driving Risk in Patients with Narcolepsy

Catherine A McCall,1,2 Nathaniel F Watson3 1Department of Pulmonary, Critical Care, and Sleep Medicine, VA Puget Sound Health Care System, Seattle, WA, USA; 2Department of Psychiatry and Behavioral Sciences, University of Washington Sleep Medicine Center, Seattle, WA, USA; 3Department of Neurology,...

Full description

Bibliographic Details
Main Authors: McCall CA, Watson NF
Format: Article
Language:English
Published: Dove Medical Press 2020-11-01
Series:Therapeutics and Clinical Risk Management
Subjects:
Online Access:https://www.dovepress.com/therapeutic-strategies-for-mitigating-driving-risk-in-patients-with-na-peer-reviewed-article-TCRM
id doaj-4cf6b665b22d4c05ab537c2476f43dc4
record_format Article
spelling doaj-4cf6b665b22d4c05ab537c2476f43dc42020-11-25T04:08:06ZengDove Medical PressTherapeutics and Clinical Risk Management1178-203X2020-11-01Volume 161099110859211Therapeutic Strategies for Mitigating Driving Risk in Patients with NarcolepsyMcCall CAWatson NFCatherine A McCall,1,2 Nathaniel F Watson3 1Department of Pulmonary, Critical Care, and Sleep Medicine, VA Puget Sound Health Care System, Seattle, WA, USA; 2Department of Psychiatry and Behavioral Sciences, University of Washington Sleep Medicine Center, Seattle, WA, USA; 3Department of Neurology, University of Washington Sleep Medicine Center, Seattle, WA, USACorrespondence: Catherine A McCallVA Puget Sound Health Care System, 1660 S. Columbian Way, Seattle, WA 98108, USAEmail cmccall1@uw.eduAbstract: Narcolepsy is a central nervous system hypersomnia disorder characterized by uncontrollable episodes of daytime sleep, sleep state instability, and cataplexy (sudden loss of muscle tone precipitated by emotion). Individuals with narcolepsy report more frequent sleep-related crashes, near crashes, and drowsy driving than drivers with other sleep disorders. As such, evaluating risk of sleep-related crashes is of great importance for this patient population. There are no established guidelines for ensuring driving safety in patients with narcolepsy; however, many providers currently use a combination of subjective report, report of prior crashes or near-misses, report of previously falling asleep while driving, sleepiness screening tools, and maintenance of wakefulness testing (MWT) to determine risk. Driving simulator tests, though often unavailable to the clinician, provide data to support the use of MWT for evaluation of alertness in drivers with narcolepsy. Treatments such as modafinil may improve driving performance; however, the impact of other treatments such as stimulants and sodium oxybate on driving has not been extensively studied. Behavioral and lifestyle modifications may also reduce risk, including scheduled naps, driving only short distances, and avoiding driving after meals, sedating medications, and alcohol intake. Even with effective treatment, alertness in patients with narcolepsy may never reach that of normal drivers; however, studies have suggested that narcolepsy patients may be able to drive safely with appropriate limitations.Keywords: narcolepsy, cataplexy, driving, safetyhttps://www.dovepress.com/therapeutic-strategies-for-mitigating-driving-risk-in-patients-with-na-peer-reviewed-article-TCRMnarcolepsycataplexydrivingsafety
collection DOAJ
language English
format Article
sources DOAJ
author McCall CA
Watson NF
spellingShingle McCall CA
Watson NF
Therapeutic Strategies for Mitigating Driving Risk in Patients with Narcolepsy
Therapeutics and Clinical Risk Management
narcolepsy
cataplexy
driving
safety
author_facet McCall CA
Watson NF
author_sort McCall CA
title Therapeutic Strategies for Mitigating Driving Risk in Patients with Narcolepsy
title_short Therapeutic Strategies for Mitigating Driving Risk in Patients with Narcolepsy
title_full Therapeutic Strategies for Mitigating Driving Risk in Patients with Narcolepsy
title_fullStr Therapeutic Strategies for Mitigating Driving Risk in Patients with Narcolepsy
title_full_unstemmed Therapeutic Strategies for Mitigating Driving Risk in Patients with Narcolepsy
title_sort therapeutic strategies for mitigating driving risk in patients with narcolepsy
publisher Dove Medical Press
series Therapeutics and Clinical Risk Management
issn 1178-203X
publishDate 2020-11-01
description Catherine A McCall,1,2 Nathaniel F Watson3 1Department of Pulmonary, Critical Care, and Sleep Medicine, VA Puget Sound Health Care System, Seattle, WA, USA; 2Department of Psychiatry and Behavioral Sciences, University of Washington Sleep Medicine Center, Seattle, WA, USA; 3Department of Neurology, University of Washington Sleep Medicine Center, Seattle, WA, USACorrespondence: Catherine A McCallVA Puget Sound Health Care System, 1660 S. Columbian Way, Seattle, WA 98108, USAEmail cmccall1@uw.eduAbstract: Narcolepsy is a central nervous system hypersomnia disorder characterized by uncontrollable episodes of daytime sleep, sleep state instability, and cataplexy (sudden loss of muscle tone precipitated by emotion). Individuals with narcolepsy report more frequent sleep-related crashes, near crashes, and drowsy driving than drivers with other sleep disorders. As such, evaluating risk of sleep-related crashes is of great importance for this patient population. There are no established guidelines for ensuring driving safety in patients with narcolepsy; however, many providers currently use a combination of subjective report, report of prior crashes or near-misses, report of previously falling asleep while driving, sleepiness screening tools, and maintenance of wakefulness testing (MWT) to determine risk. Driving simulator tests, though often unavailable to the clinician, provide data to support the use of MWT for evaluation of alertness in drivers with narcolepsy. Treatments such as modafinil may improve driving performance; however, the impact of other treatments such as stimulants and sodium oxybate on driving has not been extensively studied. Behavioral and lifestyle modifications may also reduce risk, including scheduled naps, driving only short distances, and avoiding driving after meals, sedating medications, and alcohol intake. Even with effective treatment, alertness in patients with narcolepsy may never reach that of normal drivers; however, studies have suggested that narcolepsy patients may be able to drive safely with appropriate limitations.Keywords: narcolepsy, cataplexy, driving, safety
topic narcolepsy
cataplexy
driving
safety
url https://www.dovepress.com/therapeutic-strategies-for-mitigating-driving-risk-in-patients-with-na-peer-reviewed-article-TCRM
work_keys_str_mv AT mccallca therapeuticstrategiesformitigatingdrivingriskinpatientswithnarcolepsy
AT watsonnf therapeuticstrategiesformitigatingdrivingriskinpatientswithnarcolepsy
_version_ 1724426763484790784